JP2024542001A5 - - Google Patents
Info
- Publication number
- JP2024542001A5 JP2024542001A5 JP2024525459A JP2024525459A JP2024542001A5 JP 2024542001 A5 JP2024542001 A5 JP 2024542001A5 JP 2024525459 A JP2024525459 A JP 2024525459A JP 2024525459 A JP2024525459 A JP 2024525459A JP 2024542001 A5 JP2024542001 A5 JP 2024542001A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- independently selected
- nr8r9
- glycero
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273421P | 2021-10-29 | 2021-10-29 | |
| US63/273,421 | 2021-10-29 | ||
| US202263308180P | 2022-02-09 | 2022-02-09 | |
| US63/308,180 | 2022-02-09 | ||
| US202263395243P | 2022-08-04 | 2022-08-04 | |
| US63/395,243 | 2022-08-04 | ||
| PCT/US2022/048223 WO2023076598A1 (en) | 2021-10-29 | 2022-10-28 | Lipid amines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542001A JP2024542001A (ja) | 2024-11-13 |
| JP2024542001A5 true JP2024542001A5 (enExample) | 2025-11-17 |
Family
ID=84365358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525459A Pending JP2024542001A (ja) | 2021-10-29 | 2022-10-28 | 脂質アミン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260109732A1 (enExample) |
| EP (1) | EP4423107A1 (enExample) |
| JP (1) | JP2024542001A (enExample) |
| TW (1) | TW202332467A (enExample) |
| WO (1) | WO2023076598A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118324841A (zh) * | 2023-01-10 | 2024-07-12 | 辽宁键凯科技有限公司 | 一种类固醇-阳离子脂质化合物及其应用 |
| CN121487722A (zh) * | 2023-04-14 | 2026-02-06 | 北京剂泰生命科技有限公司 | 靶向脾的脂质纳米颗粒 |
| AU2024265267A1 (en) * | 2023-05-03 | 2025-11-20 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| WO2024249920A2 (en) * | 2023-05-31 | 2024-12-05 | Northwestern University | Lipid-gold salt molecules and formulation in lipid nanoparticle delivery systems |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| DE19631189A1 (de) * | 1996-08-02 | 1998-02-05 | Max Delbrueck Centrum | Neuartige kationische Amphiphile für den liposomalen Gentransfer |
| US5942634A (en) * | 1997-05-09 | 1999-08-24 | Genzyme Corporation | Cationic amphiphiles for cell transfections |
| US6169078B1 (en) * | 1998-05-12 | 2001-01-02 | University Of Florida | Materials and methods for the intracellular delivery of substances |
| US6656498B1 (en) * | 1998-11-25 | 2003-12-02 | Vanderbilt University | Cationic liposomes for gene transfer |
| FR2797188A1 (fr) * | 1999-08-04 | 2001-02-09 | Univ Paris Nord Laboratoire De | Composes lipidiques cationiques et leurs utilisation pour le transfert de substances d'interet therapeutique chargees negativement |
| JP5902197B2 (ja) | 2011-01-11 | 2016-04-13 | アルニラム・ファーマシューティカルズ・インコーポレーテッド | Ｐｅｇ化脂質および薬剤送達のためのそれらの使用 |
| WO2014172045A1 (en) | 2013-03-15 | 2014-10-23 | The University Of British Columbia | Lipid nanoparticles for transfection and related methods |
| WO2015198326A1 (en) * | 2014-06-26 | 2015-12-30 | Ramot At Tel-Aviv University Ltd. | Liposomal formulations for delivery of nucleic acids |
| EP4710943A3 (en) * | 2015-08-28 | 2026-04-29 | Molecular Transfer, Inc. | Transfection complexes and methods of using the same |
| JP2023538260A (ja) * | 2020-08-06 | 2023-09-07 | モダーナティエックス・インコーポレイテッド | ペイロード分子を気道上皮に送達するための組成物 |
| WO2022104131A1 (en) * | 2020-11-13 | 2022-05-19 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
-
2022
- 2022-10-28 WO PCT/US2022/048223 patent/WO2023076598A1/en not_active Ceased
- 2022-10-28 US US18/705,135 patent/US20260109732A1/en active Pending
- 2022-10-28 TW TW111141006A patent/TW202332467A/zh unknown
- 2022-10-28 JP JP2024525459A patent/JP2024542001A/ja active Pending
- 2022-10-28 EP EP22814249.3A patent/EP4423107A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538260A5 (enExample) | ||
| IT9048260A1 (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
| Barnes | The properties of inhaled corticosteroids: similarities and differences | |
| JP6609286B2 (ja) | ヒトにおける炎症性障害の治療用リポソームコルチコステロイド | |
| JP2021522163A (ja) | 肺疾患の処置に使用するための吸入可能なリポソーム徐放性組成物 | |
| WO2015138423A1 (en) | Prostacylin compositions and methods for using the same | |
| RU2013140706A (ru) | Сухие порошковые композиции в виде частиц, которые содержат два или более активных ингредиента, для лечения обструктивных или воспалительных заболеваний дыхательных путей | |
| KR20100063116A (ko) | 치료제들의 복합제 | |
| JP2008512446A (ja) | グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物 | |
| IT9048261A1 (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
| JP2024527940A5 (enExample) | ||
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| JP2025504430A5 (enExample) | ||
| TWI767133B (zh) | 含有治療憂鬱症或焦慮症之治療劑的緩釋組合物及其用途 | |
| US20170050945A1 (en) | Compositions and methods for the treatment of sarcoidosis | |
| CN107496388B (zh) | 一种含有福莫特罗和噻托铵盐组合物的粉状制剂及其制备方法 | |
| JP4755495B2 (ja) | 組合せ医薬品 | |
| KR20180035840A (ko) | S1p 수용체 조절제를 포함하는 조성물 | |
| TWI853932B (zh) | 用於治療肺部疾病之可吸入的支氣管擴張劑緩釋組成物 | |
| JP6684275B2 (ja) | ブデソニド及びホルモテロールを含有する医薬組成物 | |
| US20250120986A1 (en) | Sterol therapy | |
| HK40066938B (zh) | 用於治疗肺部疾病的可吸入支气管扩张剂缓释组合物 | |
| HK40066938A (zh) | 用於治疗肺部疾病的可吸入支气管扩张剂缓释组合物 | |
| NZ820531A (en) | Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof | |
| IT202100019355A1 (it) | Sale sodico della budesonide 21-fosfato per uso come antinfiammatorio e antiasmatico - budesonide 21-phosphate sodium salt for use as anti-inflammatory or anti-asthmatic agent |